Rating Change
Canaccord Genuity analysts reiterated a Buy rating on Progyny, Inc. (NASDAQ:PGNY) on July 21, 2026.
reiterateNASDAQ:PGNY
Canaccord Genuity Reiterates Buy Rating on Progyny, Inc. (PGNY)
Rating Change Canaccord Genuity analysts reiterated a Buy rating on Progyny, Inc. (NASDAQ:PGNY) on July 21, 2026. Market Context Progyny, Inc.
Market Context
Progyny, Inc. operates in the Healthcare sector. The stock currently trades at $31.93 with a market capitalization of $2.2B.
Analyst coverage from Canaccord Genuity provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Progyny, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Progyny, Inc.
Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 21, 2026 | Canaccord Genuity | Buy | N/A |
| Jul 13, 2026 | Keybanc | Overweight | N/A |
| Jun 22, 2026 | Truist Securities | Buy | N/A |
| Jun 02, 2026 | B of A Securities | Buy | N/A |
| May 19, 2026 | Canaccord Genuity | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View PGNY Stock Page
Frequently Asked Questions
What does a Buy rating mean for PGNY?
A Buy rating from Canaccord Genuity reflects the analyst's outlook on Progyny, Inc. (NASDAQ:PGNY). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the PGNY forecast page.